Groupe Hospitalier Diaconesses Croix Saint Simon — Clinical Trial Site

104 Registered trials

46 Currently recruiting

Organisation

Groupe Hospitalier Diaconesses Croix Saint Simon

Location

Paris, France

Identifier

ORG-100043407

Address

95 Rue De Reuilly, 75012, France

Departments

2107 Rheumatology
2314 Oncology Medical
Assistance Médicale à la Procréation
Chirurgie Digestive
Department of Internal Medicine
Department of Oncology
Department of Proctology
Gastro-Enterology
Gastroenterology
Infectiologie
Intensive care medicine
Internal medecine
Internal Medicine
Laboratoire de Biologie de la reproduction
Médecine Interne
Médecine Interne et Infectiologie
Médecine interne et rhumatologie
Medical oncology
Medical Oncology - Avron Site
Medical Oncology – Avron Site
Medical oncology department
ONCOLOGIE
Oncologie médicale
ONCOLOGIE OPTION MEDICALE
Oncology
Oncology department
Paris
PROCTOLOGIE
Proctology
Rheumatology
Rhumatologie
Service d'oncologie médicale
Service d’oncologie médicale
Service de Proctologie
Service Medecine Interne
Site Avron - Oncologie médicale
URCEC
Urologie
Urology depatment

Clinical trials at this site (104)

Search interface

Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc… Not authorised

2024-515603-19-00 Localized digestive Neuroendocrine Carcinomas 4
Topical Clobetasol Propionate for Inflammatory Hand osteoarthritis: A randomized trial versus placebo.(PROCLAME) Not authorised

2025-520678-20-00 Adult patients with symptomatic and inflammatory Hand o 5
Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc… Pending

2024-515603-19-01 Localized digestive Neuroendocrine Carcinomas 4
TociCCAre - Clinical trial evaluating tocilizumab for the treatment of chondrocalcinosis Pending

2024-515956-19-00 Chondrocalcinosis 5
TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma: A single-arm Phas… Pending

2024-516182-37-01 Maintenance treatment in patients with locally advanced 4
Bosentan in the treatment of Giant Cell Arteritis Pending

2024-517030-17-00 Newly diagnosed or relapsing Giant-cell arteritis 4
A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient… Pending

2024-517621-54-00 High-risk non-muscle invasive bladder cancer (NMIBC) af 5
EFFICACY OF USUAL MANAGEMENT BY LOCAL ANESTHETIC INFILTRATION IN THE TREATMENT OF CHRONIC IDIOPATHIC ANO-PERINEAL PAIN: A RANDOMIZED DOUBLE-… Pending

2024-518148-19-00 chronic idiopathic ano-perineal pain 5
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Cancer-Associated Thrombosis (CAT). 5
Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in pa… Pending

2024-520140-42-00 Patients with primary HPV high-grade squamous intra-epi 5
MAINRITSys : Rituximab vs placebo for maintenance in systemic sclerosis – interstitial lung disease Pending

2025-521331-36-00 Patient with stabilized SSc-ILD (as defined by a declin 10
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizu… Pending

2025-521587-35-00 Metastatic colorectal cancer 5
Study evaluating two treatment strategies for rectal cancer in patients ≥75 years old Pending

2025-521619-37-00 Patients ≥75 years old with cT3/T4 rectal adenocarcinom 5
Evaluation of the efficacy of corticosteroids in septic arthritis in adults: Randomized double-blind controlled trial [CORSAR] Pending

2025-522193-37-00 Septic arthritis 5
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting

2025-522255-25-00 Fallopian Tube Neoplasms 5 2026-05-18
NoLEEta - Phase III non-inferiority trial of chemotherapy de-escalation in hormone receptorpositive, Her2-negative, intermediate-risk early … Recruiting

2025-520979-13-00 Patients with HR+ HER2- early breast cancer at intermed 5 2025-12-18
A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o… Recruiting

2023-508056-19-00 HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Profi 5 2025-10-02
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-022) Recruiting

2023-508015-23-00 Ovarian cancer recurrent 5 2025-04-11
A Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors Recruiting

2023-510275-64-00 Hepatocellular carcinoma, colorectal cancer, endometria 9 2023-05-31
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF MIGALASTAT HCL IN SUBJECTS WITH FABRY DISEASE AND AMENABLE GLA VARIANTS A… Recruiting

2022-500488-10-00 Fabry Disease and Amenable GLA Variants and Severe Rena 5 2022-12-19
PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with … Recruiting

2023-505046-26-00 Colon carcinoma 5 2026-05-07
PRODIGE 115 (FFCD 2406) ULYSSE : FOLFOX/FOLFIRI + Bévacizumab ou Fruquintinib en 2ème ligne du Cancer Colorectal métastatique (CCRm) : essai… Recruiting

2025-522108-26-00 métastatique colorectal cancer 4 2026-02-19
A Global Phase III Study of Puxitatug Samrotecan (AZD8205) Monotherapy Compared with Physician’s Choice of Chemotherapy for B7-H4-Selected E… Recruiting

2024-518777-34-00 B7-H4-Selected Advanced/Metastatic Endometrial Cancer. 5 2026-02-11